A research team has introduced a novel technology capable of removing inflammation-triggering agents in extracorporeal blood. The team, led by Professors Joo Hun Kang and Jinmyoung Joo in the Department of Biomedical Engineering at UNIST, in collaboration with Professor Jae Hyuk Lee from Seoul National University Bundang Hospital, anticipates that this innovation will open avenues for sepsis treatment by demonstrating excellent therapeutic effects under conditions similar to those of actual patients.